E
Medicenna Therapeutics Corp. MDNA.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -19.73M -19.68M -19.40M -18.88M -11.42M
Total Depreciation and Amortization 25.40K 13.20K 5.80K 2.80K 2.80K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 8.12M 7.52M 7.27M 6.27M -659.20K
Change in Net Operating Assets -364.80K -222.80K 953.90K 547.70K 1.91M
Cash from Operations -11.95M -12.37M -11.18M -12.06M -10.16M
Capital Expenditure -24.20K -24.20K -22.70K -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -24.20K -24.20K -22.70K -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 23.81M 21.90M 20.90M -- --
Repurchase of Common Stock -- -- -- -- -189.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -300.00K -300.00K -- -- --
Cash from Financing 17.15M 15.79M 15.27M -- -139.70K
Foreign Exchange rate Adjustments 784.70K -13.40K 197.00K -264.60K -372.70K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 5.96M 3.38M 4.27M -12.32M -10.67M
Weiss Ratings